| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |